题名 | Unveiling the molecular complexity of proliferative diabetic retinopathy through scRNA-seq, AlphaFold 2, and machine learning |
作者 | |
通讯作者 | Pu, Zuhui; Yang, Ming-ming |
发表日期 | 2024-05-10
|
DOI | |
发表期刊 | |
ISSN | 1664-2392
|
卷号 | 15 |
摘要 | Background Proliferative diabetic retinopathy (PDR), a major cause of blindness, is characterized by complex pathogenesis. This study integrates single-cell RNA sequencing (scRNA-seq), Non-negative Matrix Factorization (NMF), machine learning, and AlphaFold 2 methods to explore the molecular level of PDR.Methods We analyzed scRNA-seq data from PDR patients and healthy controls to identify distinct cellular subtypes and gene expression patterns. NMF was used to define specific transcriptional programs in PDR. The oxidative stress-related genes (ORGs) identified within Meta-Program 1 were utilized to construct a predictive model using twelve machine learning algorithms. Furthermore, we employed AlphaFold 2 for the prediction of protein structures, complementing this with molecular docking to validate the structural foundation of potential therapeutic targets. We also analyzed protein-protein interaction (PPI) networks and the interplay among key ORGs.Results Our scRNA-seq analysis revealed five major cell types and 14 subcell types in PDR patients, with significant differences in gene expression compared to those in controls. We identified three key meta-programs underscoring the role of microglia in the pathogenesis of PDR. Three critical ORGs (ALKBH1, PSIP1, and ATP13A2) were identified, with the best-performing predictive model demonstrating high accuracy (AUC of 0.989 in the training cohort and 0.833 in the validation cohort). Moreover, AlphaFold 2 predictions combined with molecular docking revealed that resveratrol has a strong affinity for ALKBH1, indicating its potential as a targeted therapeutic agent. PPI network analysis, revealed a complex network of interactions among the hub ORGs and other genes, suggesting a collective role in PDR pathogenesis.Conclusion This study provides insights into the cellular and molecular aspects of PDR, identifying potential biomarkers and therapeutic targets using advanced technological approaches. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 通讯
|
资助项目 | Shenzhen Science and Technology Program["JCYJ20220818102603007","GCZX2015043017281705"]
; General Project of the Shenzhen Natural Science Foundation["JCYJ20210324113808023","JCYJ20220530152813030"]
|
WOS研究方向 | Endocrinology & Metabolism
|
WOS类目 | Endocrinology & Metabolism
|
WOS记录号 | WOS:001229865200001
|
出版者 | |
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:3
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/788367 |
专题 | 南方科技大学第一附属医院 |
作者单位 | 1.Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Endocrinol, Shenzhen, Peoples R China 2.Southern Univ Sci & Technol, Affiliated Hosp 1, Shenzhen, Peoples R China 3.Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Ophthalmol, Shenzhen, Peoples R China 4.Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Inst Translat Med,Imaging Dept, Shenzhen, Peoples R China 5.Shenzhen Inst Translat Med, MetaLife Ctr, Shenzhen, Guangdong, Peoples R China |
第一作者单位 | 南方科技大学第一附属医院 |
通讯作者单位 | 南方科技大学第一附属医院 |
推荐引用方式 GB/T 7714 |
Wang, Jun,Sun, Hongyan,Mou, Lisha,et al. Unveiling the molecular complexity of proliferative diabetic retinopathy through scRNA-seq, AlphaFold 2, and machine learning[J]. FRONTIERS IN ENDOCRINOLOGY,2024,15.
|
APA |
Wang, Jun.,Sun, Hongyan.,Mou, Lisha.,Lu, Ying.,Wu, Zijing.,...&Yang, Ming-ming.(2024).Unveiling the molecular complexity of proliferative diabetic retinopathy through scRNA-seq, AlphaFold 2, and machine learning.FRONTIERS IN ENDOCRINOLOGY,15.
|
MLA |
Wang, Jun,et al."Unveiling the molecular complexity of proliferative diabetic retinopathy through scRNA-seq, AlphaFold 2, and machine learning".FRONTIERS IN ENDOCRINOLOGY 15(2024).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论